Burdick Companies Medical Tr
Burdick Companies Medical Tr reports a $463,446 deficit in its latest fiscal year after consistent surpluses.
EIN: 161430485 · Cicero, NY · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $2.7M |
| Total Expenses | $3.3M |
| Program Spending | 80% |
| Net Assets | $1.7M |
| Transparency Score | 75/100 |
Is Burdick Companies Medical Tr Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Burdick Companies Medical Tr directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Burdick Companies Medical Tr
Burdick Companies Medical Tr (EIN: 161430485) is a nonprofit organization based in Cicero, NY. The organization reported total revenue of $2.7M and total assets of $1.3M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Burdick Companies Medical Tr's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Burdick Companies Medical Tr is a mid-size nonprofit that has been operating for 32 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 3.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $2.9M |
| Total Expenses | $3.3M |
| Surplus / Deficit | $-463,446 |
| Total Assets | $1.9M |
| Total Liabilities | $221K |
| Net Assets | $1.7M |
| Operating Margin | -16.1% |
| Debt-to-Asset Ratio | 11.6% |
| Months of Reserves | 6.8 months |
Financial Health Grade: B
In 2023, Burdick Companies Medical Tr reported a deficit of $463K with expenses exceeding revenue, holds 6.8 months of operating reserves (strong position), has a debt-to-asset ratio of 11.6% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Burdick Companies Medical Tr's revenue has grown at a compound annual growth rate (CAGR) of 3.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +18.2% | +49.8% | -19.6% |
| 2022 | +18.3% | +27.3% | +9.6% |
| 2021 | -12.8% | -30.4% | +16.6% |
| 2020 | +6.5% | +27.9% | -7.7% |
| 2019 | +4.1% | -2.6% | +14.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1994 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Burdick Companies Medical Tr with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 80%
- fundraising: 5%
According to IRS 990 filings, Burdick Companies Medical Tr allocates its expenses as follows: admin: 15%, programs: 80%, fundraising: 5%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $463K, with expenses exceeding revenue.
- Debt-to-asset ratio: 11.6%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, indicating that executive leadership is either entirely volunteer-based or compensated through non-officer roles, which enhances financial efficiency but could obscure total leadership costs.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Burdick Companies Medical Tr's IRS 990 filings:
- Significant operational deficit in the latest fiscal year (202312) of $463,446, a departure from historical surpluses.
- Lack of detailed expense breakdown (program, admin, fundraising) in the provided data, hindering full spending efficiency analysis.
- Unknown NTEE code and unspecified mission, limiting understanding of programmatic focus.
Strengths
The following positive indicators were identified for Burdick Companies Medical Tr:
- Consistent revenue generation, averaging over $2 million annually, indicating a stable funding base.
- Long operating history with 13 filings, suggesting organizational stability and experience.
- Low liabilities relative to assets, indicating a healthy balance sheet.
- Consistent reporting of 0% officer compensation, potentially indicating high efficiency in leadership costs.
Frequently Asked Questions about Burdick Companies Medical Tr
Is Burdick Companies Medical Tr a legitimate charity?
Burdick Companies Medical Tr (EIN: 161430485) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 75/100. It has 13 years of IRS 990 filings on record. Total revenue: $2.7M. 3 red flags identified. 4 strengths noted. Financial health grade: B.
How does Burdick Companies Medical Tr spend its money?
Burdick Companies Medical Tr directs 80% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Burdick Companies Medical Tr tax-deductible?
Burdick Companies Medical Tr is registered as a tax-exempt nonprofit (EIN: 161430485). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Burdick Companies Medical Tr's spending goes to programs?
Burdick Companies Medical Tr directs 80% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
Where is Burdick Companies Medical Tr located?
Burdick Companies Medical Tr is headquartered in Cicero, New York and files with the IRS under EIN 161430485.
How many years of IRS 990 filings does Burdick Companies Medical Tr have?
Burdick Companies Medical Tr has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $2.7M in total revenue.
What caused the significant increase in expenses in the 202312 period, leading to a $463,446 deficit?
The provided data does not specify the nature of the increased expenses, making it difficult to pinpoint the exact cause of the deficit in the 202312 fiscal year.
How does Burdick Companies Medical Tr manage to report 0% officer compensation consistently?
The consistent reporting of 0% officer compensation suggests that the organization's leadership may be entirely volunteer-based or that compensation is categorized differently, such as under general salaries or other expenses, rather than specifically as officer compensation.
What is the NTEE code and specific mission of Burdick Companies Medical Tr?
The NTEE code is listed as 'Unknown' in the provided data, and the specific mission is not detailed, making it difficult to fully assess its programmatic impact.
What is the organization's strategy for addressing the recent operational deficit and returning to a surplus?
The provided financial data does not include information on the organization's strategic plans or responses to the recent operational deficit.
Filing History
IRS 990 filing history for Burdick Companies Medical Tr showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Burdick Companies Medical Tr's revenue has grown by 57.9%, moving from $1.8M to $2.9M. Total assets increased by 727.9% over the same period, from $230K to $1.9M. Total functional expenses rose by 79.4%, from $1.9M to $3.3M. In its most recent filing year (2023), Burdick Companies Medical Tr reported a deficit of $463K, with expenses exceeding revenue. The organization holds $221K in liabilities against $1.9M in assets (debt-to-asset ratio: 11.6%), resulting in net assets of $1.7M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $2.9M | $3.3M | $1.9M | $221K | — | — |
| 2022 | $2.4M | $2.2M | $2.4M | $190K | — | View 990 |
| 2021 | $2.1M | $1.8M | $2.2M | $175K | — | View 990 |
| 2020 | $2.4M | $2.5M | $1.8M | $70K | — | — |
| 2019 | $2.2M | $2.0M | $2.0M | $179K | — | View 990 |
| 2018 | $2.1M | $2.0M | $1.8M | $176K | — | View 990 |
| 2017 | $2.3M | $1.9M | $1.6M | $175K | — | View 990 |
| 2016 | $2.6M | $2.0M | $1.2M | $275K | — | View 990 |
| 2015 | $2.5M | $2.0M | $1.2M | $607K | — | View 990 |
| 2014 | $2.2M | $2.0M | $763K | $79K | — | View 990 |
| 2013 | $2.2M | $1.8M | $542K | $151K | — | View 990 |
| 2012 | $2.2M | $2.3M | $150K | $119K | — | View 990 |
| 2011 | $1.8M | $1.9M | $230K | $195K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $2.9M, expenses of $3.3M, and assets of $1.9M (revenue +18.2% year-over-year).
- 2022: Revenue of $2.4M, expenses of $2.2M, and assets of $2.4M (revenue +18.3% year-over-year).
- 2021: Revenue of $2.1M, expenses of $1.8M, and assets of $2.2M (revenue -12.8% year-over-year).
- 2020: Revenue of $2.4M, expenses of $2.5M, and assets of $1.8M (revenue +6.5% year-over-year).
- 2019: Revenue of $2.2M, expenses of $2.0M, and assets of $2.0M (revenue +4.1% year-over-year).
- 2018: Revenue of $2.1M, expenses of $2.0M, and assets of $1.8M (revenue -8.3% year-over-year).
- 2017: Revenue of $2.3M, expenses of $1.9M, and assets of $1.6M (revenue -8.7% year-over-year).
- 2016: Revenue of $2.6M, expenses of $2.0M, and assets of $1.2M (revenue +4.0% year-over-year).
- 2015: Revenue of $2.5M, expenses of $2.0M, and assets of $1.2M (revenue +9.5% year-over-year).
- 2014: Revenue of $2.2M, expenses of $2.0M, and assets of $763K (revenue +2.6% year-over-year).
- 2013: Revenue of $2.2M, expenses of $1.8M, and assets of $542K (revenue -1.5% year-over-year).
- 2012: Revenue of $2.2M, expenses of $2.3M, and assets of $150K (revenue +21.3% year-over-year).
- 2011: Revenue of $1.8M, expenses of $1.9M, and assets of $230K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Burdick Companies Medical Tr:
Data Sources and Methodology
This transparency report for Burdick Companies Medical Tr is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.